YC bio and healthcare companies are helping with the COVID-19 crisis, whether to produce better tests, treatments, and vaccines or resources for hospitals and health systems.

In this free report, we have examined 5 of the selected companies and their patent/investment portfolios.

Get in touch to have access to thousands of key players in the field.

Ginkgo Bioworks designs, engineers, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals.

Gingko Bioworks also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Ginkgo has been valued at $4.2B from its latest "Series E" round on Sep 19, 2019. The company has also acquired Gen9 & Warp Drive Bio, as well as made over $370M investments to date.

This figure shows the leading ten organizations in the subject technology field. The organization with the largest portfolio is on the top.

This graph shows the number of investments in different investment types.

Get in touch to learn more about interactive reports. Register now!